Tag Archives: The Stem Cell Blog

Merck, riding clinical success, eyes cancer immunotherapy lead – BioPharma Dive

Continue reading

2018-05-01 NEWS

Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 NEWS

Miami Herald

Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive
Merck & Co.’s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma’s top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of
Merck lifts earnings forecast after currency boostFinancial Times

all 101 news articles »

Continue reading

2018-05-01 NEWS

Eureka Times Standard

UC vs. Harvard: Round 2 in CRISPR gene technology fight
Eureka Times Standard
It’s a high stakes showdown over intellectual-property rights between two of the nation’s most prestigious institutions, with perhaps a billion dollars in the balance. While research universities often reach settlements over patent disputes, both sides